Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan
· Delayed Price · Currency is TWD 788.00
-57.00 (-6.75%)
At close: Mar 31, 2025
TPE:6919 Revenue
In the year 2024, Caliway Biopharmaceuticals had annual revenue of 44.43M TWD with 14.13% growth. Caliway Biopharmaceuticals had revenue of 9.36M in the quarter ending December 31, 2024, a decrease of -37.19%.
Revenue
44.43M
Revenue Growth
+14.13%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
121.22B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 9.73B |
| Bora Pharmaceuticals Co., LTD. | 19.25B |
| Lotus Pharmaceutical | 18.58B |
| Oneness Biotech | 117.93M |
| Lumosa Therapeutics | 39.15M |
| Pegavision | 6.82B |
| Polaris Group | 107.00M |
| Center Laboratories | 1.62B |